These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12781177)

  • 21. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S; Nomikos GG; Panagis G
    Psychopharmacology (Berl); 2006 Oct; 188(3):293-305. PubMed ID: 16953388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C; Markert A; Zimmer A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocannabinoid modulation of male rat sexual behavior.
    Gorzalka BB; Morrish AC; Hill MN
    Psychopharmacology (Berl); 2008 Jul; 198(4):479-86. PubMed ID: 17694389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
    Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
    Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kavalactones and the endocannabinoid system: the plant-derived yangonin is a novel CB₁ receptor ligand.
    Ligresti A; Villano R; Allarà M; Ujváry I; Di Marzo V
    Pharmacol Res; 2012 Aug; 66(2):163-9. PubMed ID: 22525682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
    Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
    Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of (13S)-methyl-substituted arachidonic acid analogues: templates for novel endocannabinoids.
    Papahatjis DP; Nahmias VR; Nikas SP; Schimpgen M; Makriyannis A
    Chemistry; 2010 Apr; 16(13):4091-9. PubMed ID: 20187040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
    Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
    J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus.
    Gobira PH; Lima IV; Batista LA; de Oliveira AC; Resstel LB; Wotjak CT; Aguiar DC; Moreira FA
    J Psychopharmacol; 2017 Jun; 31(6):750-756. PubMed ID: 28583049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of all-trans anandamide: a substrate for fatty acid amide hydrolase with dual effects on rabbit platelet activation.
    Ferreri C; Anagnostopoulos D; Lykakis IN; Chatgilialoglu C; Siafaka-Kapadai A
    Bioorg Med Chem; 2008 Sep; 16(18):8359-65. PubMed ID: 18782671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocannabinoid system in Xenopus laevis development: CB1 receptor dynamics.
    Migliarini B; Marucci G; Ghelfi F; Carnevali O
    FEBS Lett; 2006 Apr; 580(8):1941-5. PubMed ID: 16519888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAAH and anandamide: is 2-AG really the odd one out?
    Di Marzo V; Maccarrone M
    Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus.
    Soria-Gómez E; Matias I; Rueda-Orozco PE; Cisneros M; Petrosino S; Navarro L; Di Marzo V; Prospéro-García O
    Br J Pharmacol; 2007 Aug; 151(7):1109-16. PubMed ID: 17549045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocannabinoid system in frog and rodent testis: type-1 cannabinoid receptor and fatty acid amide hydrolase activity in male germ cells.
    Cobellis G; Cacciola G; Scarpa D; Meccariello R; Chianese R; Franzoni MF; Mackie K; Pierantoni R; Fasano S
    Biol Reprod; 2006 Jul; 75(1):82-9. PubMed ID: 16611862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro.
    Iuvone T; Esposito G; De Filippis D; Bisogno T; Petrosino S; Scuderi C; Di Marzo V; Steardo L;
    J Mol Med (Berl); 2007 Dec; 85(12):1379-92. PubMed ID: 17639288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
    Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
    Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability.
    Francavilla F; Battista N; Barbonetti A; Vassallo MR; Rapino C; Antonangelo C; Pasquariello N; Catanzaro G; Barboni B; Maccarrone M
    Endocrinology; 2009 Oct; 150(10):4692-700. PubMed ID: 19608651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoids, feeding and suckling--from our perspective.
    Mechoulam R; Berry EM; Avraham Y; Di Marzo V; Fride E
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S24-8. PubMed ID: 16570101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.